Professor Leon Schurgers, PhD, a globally renowned vitamin K expert and Chair of the Department of Biochemistry at CARIM, Maastricht University, shared preliminary findings from the VitaK-CAC Trial at the esteemed Linus Pauling Institute Diet and Optimum Health Conference.
Gnosis by Lesaffre was proud to sponsor the Linus Pauling Institute “Diet and Optimum Health” conference, where new results from the VitaK-CAC study were presented.
Prof. Leon Schurgers (Maastricht University) shared compelling data showing that two years of MenaQ7® (vitamin K2 as MK-7) supplementation significantly slowed the progression of coronary artery calcification (CAC) compared to placebo — marking the first time a vitamin has demonstrated this effect in individuals with coronary artery disease.
These findings reinforce the important role of vitamin K2 in cardiovascular health and ageng. As the developer of MenaQ7®, Gnosis continues to invest in clinical research and scientific partnerships to advance evidence-based solutions for better vascular health.